title: Erythrocytosis in hairy cell leukaemia following therapy with interferon alpha.
authors.affiliation: NCI-FCRF, Frederick, MD 21701.
authors.forename: R G
authors.initials: RG
authors.lastname: Steis
authors.forename: L A
authors.initials: LA
authors.lastname: VanderMolen
authors.forename: J
authors.initials: J
authors.lastname: Lawrence
authors.forename: G
authors.initials: G
authors.lastname: Sing
authors.forename: F
authors.initials: F
authors.lastname: Ruscetti
authors.forename: J W
authors.initials: JW
authors.lastname: Smith
authors.forename: W J
authors.initials: WJ
authors.lastname: Urba
authors.forename: J
authors.initials: J
authors.lastname: Clark
authors.forename: D L
authors.initials: DL
authors.lastname: Longo
mesh_terms: D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects; D007943:Leukemia, Hairy Cell / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011086:Polycythemia / Q000209:etiology*; D011994:Recombinant Proteins
chemical_list: D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins